TW360656B - Purin-6-one derivatives having cGMP-metabolizing PDEs inhibiting activity, the preparation processes and the pharmaceutical preparation thereof - Google Patents

Purin-6-one derivatives having cGMP-metabolizing PDEs inhibiting activity, the preparation processes and the pharmaceutical preparation thereof

Info

Publication number
TW360656B
TW360656B TW085113407A TW85113407A TW360656B TW 360656 B TW360656 B TW 360656B TW 085113407 A TW085113407 A TW 085113407A TW 85113407 A TW85113407 A TW 85113407A TW 360656 B TW360656 B TW 360656B
Authority
TW
Taiwan
Prior art keywords
chain
purin
carbon atoms
straight
derivatives
Prior art date
Application number
TW085113407A
Other languages
English (en)
Inventor
Ulrich Niewohner
Erwin Bischoff
Joachim Hutter
Elisabeth Perzborn
Helmuth Schutz
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of TW360656B publication Critical patent/TW360656B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW085113407A 1995-11-06 1996-11-04 Purin-6-one derivatives having cGMP-metabolizing PDEs inhibiting activity, the preparation processes and the pharmaceutical preparation thereof TW360656B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19541264A DE19541264A1 (de) 1995-11-06 1995-11-06 Purin-6-on-derivate

Publications (1)

Publication Number Publication Date
TW360656B true TW360656B (en) 1999-06-11

Family

ID=7776713

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085113407A TW360656B (en) 1995-11-06 1996-11-04 Purin-6-one derivatives having cGMP-metabolizing PDEs inhibiting activity, the preparation processes and the pharmaceutical preparation thereof

Country Status (23)

Country Link
US (1) US5861396A (zh)
EP (1) EP0771799A1 (zh)
JP (1) JPH09124648A (zh)
KR (1) KR970027082A (zh)
AR (1) AR004545A1 (zh)
AU (1) AU720305B2 (zh)
BR (1) BR9605434A (zh)
CA (1) CA2189401A1 (zh)
CO (1) CO4770977A1 (zh)
CZ (1) CZ325096A3 (zh)
DE (1) DE19541264A1 (zh)
EE (1) EE9600172A (zh)
HU (1) HU217691B (zh)
IL (1) IL119559A0 (zh)
MX (1) MX9605371A (zh)
NO (1) NO964667L (zh)
NZ (1) NZ299683A (zh)
PL (1) PL316816A1 (zh)
SG (1) SG64953A1 (zh)
SK (1) SK142596A3 (zh)
TR (1) TR199600883A2 (zh)
TW (1) TW360656B (zh)
ZA (1) ZA969278B (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE242775T1 (de) * 1998-01-05 2003-06-15 Eisai Co Ltd Purinderivate und antagonisten des adenosin-a2- rezeptors, welche zur vorsorge oder heilung von diabetes dienen
DE19838705A1 (de) 1998-08-26 2000-03-02 Bayer Ag Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one
GB9828340D0 (en) * 1998-12-22 1999-02-17 Novartis Ag Organic compounds
IL139457A0 (en) 1999-11-08 2001-11-25 Pfizer Compounds for the treatment of female sexual dysfunction
US20050020547A1 (en) * 1999-11-08 2005-01-27 Pfizer Inc. Compounds for the treatment of female sexual dysfunction
WO2002009713A2 (de) 2000-08-01 2002-02-07 Bayer Aktiengesellschaft Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
US7501409B2 (en) * 2000-09-06 2009-03-10 Mitsubishi Tanabe Pharma Corporation Preparations for oral administration
DE10064105A1 (de) 2000-12-21 2002-06-27 Bayer Ag Neue Substituierte Imidazotriazinone
NZ527585A (en) * 2001-02-15 2005-04-29 Tanabe Seiyaku Co Tablets quickly disintegrated in oral cavity
EP1379520B2 (en) 2001-02-23 2014-04-09 Merck Sharp & Dohme Corp. N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
PL370599A1 (en) * 2001-11-02 2005-05-30 Pfizer Products Inc. Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
US20060106037A1 (en) * 2003-03-04 2006-05-18 Thomas Bar Purin-6-one-derivatives
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors
US20050054688A1 (en) * 2003-08-08 2005-03-10 Pfizer Inc Selective serotonin reuptake inhibitors in the treatment of disease
AU2004268387A1 (en) * 2003-08-28 2005-03-10 Nycomed Gmbh Composition comprising a pulmonary surfactant and a PDE2 inhibitor
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
ATE412648T1 (de) * 2005-03-21 2008-11-15 Pfizer Ltd Substituierte triazolderivate als oxytocinantagonisten
JP2008533193A (ja) * 2005-03-21 2008-08-21 ファイザー・リミテッド オキシトシン拮抗薬としての置換トリアゾール誘導体
EP1917257A1 (en) * 2005-08-10 2008-05-07 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
WO2015106032A1 (en) 2014-01-08 2015-07-16 Intra-Cellular Therapies, Inc. Products and pharmaceutical compositions
CN107205993B (zh) 2014-12-06 2021-03-09 细胞内治疗公司 有机化合物
AU2015357496B2 (en) 2014-12-06 2019-09-19 Intra-Cellular Therapies, Inc. Organic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
IL76546A (en) * 1984-10-12 1988-12-30 Warner Lambert Co 9-(heteroarylalkyl)-6-purine(thi)one derivatives,their preparation and pharmaceutical compositions containing them
JPH01501478A (ja) * 1986-11-25 1989-05-25 インスティテュト　オルガニチェスコゴ　シンテザ　アカデミイ　ナウク　ラトビイスコイ　エスエスアール ９―置換グアニン
IT1241452B (it) * 1990-06-28 1994-01-17 Sigma Tau Ind Farmaceuti Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono

Also Published As

Publication number Publication date
JPH09124648A (ja) 1997-05-13
HUP9603071A2 (en) 1997-05-28
KR970027082A (ko) 1997-06-24
SK142596A3 (en) 1997-05-07
HU217691B (hu) 2000-03-28
CA2189401A1 (en) 1997-05-07
US5861396A (en) 1999-01-19
AR004545A1 (es) 1998-12-16
BR9605434A (pt) 1998-08-04
EP0771799A1 (de) 1997-05-07
NO964667D0 (no) 1996-11-05
TR199600883A2 (tr) 1997-05-21
ZA969278B (en) 1997-06-02
EE9600172A (et) 1997-06-16
DE19541264A1 (de) 1997-05-07
CZ325096A3 (en) 1997-06-11
AU720305B2 (en) 2000-05-25
SG64953A1 (en) 1999-05-25
MX9605371A (es) 1997-05-31
NZ299683A (en) 1998-09-24
HU9603071D0 (en) 1996-12-30
CO4770977A1 (es) 1999-04-30
PL316816A1 (en) 1997-05-12
NO964667L (no) 1997-05-07
IL119559A0 (en) 1997-02-18
HUP9603071A3 (en) 1998-04-28
AU7053296A (en) 1997-05-15

Similar Documents

Publication Publication Date Title
TW360656B (en) Purin-6-one derivatives having cGMP-metabolizing PDEs inhibiting activity, the preparation processes and the pharmaceutical preparation thereof
NZ311082A (en) Aromatic compounds and pharmaceutical compositions containing same
FI900307A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista 3-/3-okso-(2,3)-dihydropyridatsin-6-yyli/-2-fenyyli-pyratsolo/1,5-a/pyridiinijohdannaisia
AU528275B2 (en) Imidazole derivatives
MY111770A (en) Short-acting dihydropyridines
HUP9900851A2 (hu) Benzotiofénszármazékok felhasználása véredény simaizom sejtek migrálásának inhibiálására alkalmas gyógyszerkészítmények előállítására
UA49089C2 (uk) Похідні вуглеводів та фармацевтична композиція на їх основі
GR3001984T3 (en) 1,4-dihydropyridines, process for their preparation and their use as medicaments
HU9300202D0 (en) Benzo-pyrane derivatives, pharmaceutical preparatives containing them as active substance as well as method for producing them
ATE40127T1 (de) 1,5-benzothiazepinderivate, verfahren zu ihrer herstellung und arzneimittel.
DE3480839D1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
FR2691464B1 (fr) Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
EP0155164A3 (en) Novel cyanoimidazole nucleoside derivatives
NO963374L (no) Substituerte 4H-pyraner
PT72359B (fr) Procede de preparation de nouveaux derives de dihydro-i,3- imidazo<1,2,-b->pyrydazines avec application en therapeutique
HUT46005A (en) Process for producing 5-hetero or aryl-substituted imidazo (2,1-a) isoquinoline derivatives and pharmaceutics comprising them as active ingredient
DE3767533D1 (de) D-nor-7-ergolinderivate, verfahren zu ihrer herstellung, pharmazeutische zubereitung und verwendung.
EP0367671A3 (en) Novel beta-d-phenylthioxylosides, their method of preparation and their use as pharmaceuticals
ATE66231T1 (de) Dioxolobenzisoxazolderivate und verfahren zu ihrer herstellung.
TH19066A (th) วิธีสำหรับยับยั้งการเพิ่มจำนวนเซลล์กล้ามเนื้อเรียบและภาวะการตีบของหลอดเลือด
TH8168B (th) วิธีสำหรับยับยั้งการเพิ่มจำนวนเซลล์กล้ามเนื้อเรียบและภาวะการตีบของหลอดเลือด
TH21502A (th) อนุพันธ์ของอิมิดาโซพิริดีนและกรรมวิธีสำหรับการเตรียมสารเหล่านั้น
TH20908B (th) อนุพันธ์คาร์โบไฮเดรต